Future treatment for ed: Growth factors and gene therapy

International Journal of Impotence Research

Volumn 11, Issue , 1999, Pages S56-S57

  Lue, T F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; ERECTILE DYSFUNCTION; GENE THERAPY; GENE TRANSFER; HUMAN; MALE; NONHUMAN; PENIS PROSTHESIS; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION;

ANIMALS; GENE THERAPY; GROWTH SUBSTANCES; HUMANS; IMPOTENCE; MALE;

EID: 0032726786     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900485     Document Type: Article

References (5)

1. Naitoh J, Belldegrun A. Gene therapy-the future is here: a guide to the practicing urologist. Urol 1998; 51: 367-380.
2. Garban H et al. Cloning of rat and human inducible penile nitric oxide synthase. Application for gene therapy of erectile dysfunction. Biology of Reproduction 1997; 56(4): 954-963.
3. Christ GJ, Melman A. The application of gene therapy to the treatment of erectile dysfunction. Int J Impot Res 1998; 10(2): 111-112.
4. Huard et al. Nitric oxide synthase (NOS) gene therapy for erectile dysfunction: comparison between plasmid, adenovirus and adenovirus transduced myoblast vectors. J Urol 1998; 159 (Suppl): 90.
5. Wessels H, Williams SK. Endothelial cell transplantation into corpus cavernosum: Basis for efficient gene therapy for erectile dysfunction. J Urol 1998; 159(5) (Suppl): 92.